Next Generation Sequencing Bioinformatics Heats Up: Nearing $1000 Genome Sparks Soaring Data Output
The decreasing cost of genome sequencing lends momentum to the global next-generation sequencing (NGS) informatics market.
Back To News Releases Discharger Dust Hood Contains Bag Spout Leaks And Spills
A new Dust Hood for Flexicon Bulk Bag Dischargers contains spillage and dust that can escape through seams in the bag and folds in the spout.
The Future Of Amyloid Detection
Solex LLC. has licensed a peptide-based technology for the diagnostic visualization of amyloid burden in patients with amyloid-related diseases by using molecular imaging techniques
King Willem-Alexander Of The Netherlands Opens The New Headquarters Of Applikon Biotechnology
On Wednesday December 4th the new headquarters of Applikon Biotechnology in Delft, the Netherlands will be opened by His Majesty King Willem-Alexander of the Netherlands.
SAFC Partners With CatScI Ltd. To Offer Comprehensive Catalysis Services
Sigma-Aldrich Corporation recently announced that SAFC Commercial , its custom manufacturing services business unit, has entered into a services agreement with CatScI Ltd., a UK-based catalysis company focused on maximizing yield, optimizing quality, reducing waste and minimizing chemical development costs through reaction understanding.
Completion Of A “First In Human” Clinical Phase I Study With A Therapeutic Protein Derived From CAP Cells
CEVEC Pharmaceuticals (“CEVEC”), the developer of a novel human expression system derived from amniocytes (CAP® Cells), announced today that a Dutch consortium led by TNO reported the safe completion of a clinical Phase I study with recombinant human Alkaline Phosphatase (hRESCAP®) derived from CEVEC’s CAP® cells.
Novozymes Biopharma Announces Collaboration With Almac
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, is delighted to announce its new collaboration with Almac, to provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic improvements. The collaboration will allow clients to utilise Almac’s world-class manufacturing assets and protein conjugation capability to link Novozymes’ Recombumin® Flex technology successfully to their peptide and small molecule drugs. This subsequently improves the pharmacokinetics and has already been shown to improve drug targeting in oncology and rheumatoid arthritis. Collaborations with commercial partners have already begun and will continue to expand in early 2014.
Expand Your Research Capabilities Using Targeted NGS
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is hosting a webinar entitled ‘Expanding your research capabilities using targeted NGS’. This educational presentation will run live on both October 29 and 30, making it accessible across multiple time zones.
3-V Biosciences Presents Novel FASN Inhibitor Of Tumor Metabolism At AACR-NCI-EORTC Conference
3‐V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key host‐cell pathways resulting in death of tumor cells or
virally‐infected cells, today presented positive data from preclinical studies of the company’s novel fatty acid synthase (FASN) inhibitors.
Rocket 4D Evaporator Ideal For Removing Large Volumes With Efficiency
Genevac has reported very positive feedback from early adopters of their Rocket 4D – a fully automated system for automatic drying or concentration of very large volumes up to 100 litres.